Development of Colon-targeted Microsponges for the Treatment of Inflammatory Bowel Disease
By: Janakidevi, S
.
Contributor(s): Ramanamurthy, K. V.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2018Edition: Vol. 80(04) July-August.Description: 604-609.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical sciencesSummary: The present study is aimed to develop and characterize microsponge-based novel colon-specific drug delivery systems containing 5-amino salicylic acid for the treatment of inflammatory bowel disease. Initially, microsponges of 5-amino salicylic acid were prepared by quasi-emulsion solvent diffusion method using Eudragit RS100, Eudragit S-100 and Eudragit L100. Different formulations of microsponges using three acid resistant polymers, Eudragit S100, Eudragit L100, Eudragit RS100 in drug:polymer ratios of 1:1, 1:0.5, 1:0.25 with each polymer were prepared and evaluated for physicochemical, morphological characteristics and in vitro parameters. Among these nine formulations, ES1, EL1 and ERS1 were selected, sieved and compressed into tablets, T-ES1, T-EL1, T-ERS1 and evaluated. Among the 3 batches of tablet formulations prepared, T-ES1 showed the best release rate for the drug, which followed zero order release kinetics with diffusion case II transport mechanism.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2018061 |
The present study is aimed to develop and characterize microsponge-based novel colon-specific drug delivery systems containing 5-amino salicylic acid for the treatment of inflammatory bowel disease. Initially, microsponges of 5-amino salicylic acid were prepared by quasi-emulsion solvent diffusion method using Eudragit RS100, Eudragit S-100 and Eudragit L100. Different formulations of microsponges using three acid resistant polymers, Eudragit S100, Eudragit L100, Eudragit RS100 in drug:polymer ratios of 1:1, 1:0.5, 1:0.25 with each polymer were prepared and evaluated for physicochemical, morphological characteristics and in vitro parameters. Among these nine formulations, ES1, EL1 and ERS1 were selected, sieved and compressed into tablets, T-ES1, T-EL1, T-ERS1 and evaluated. Among the 3 batches of tablet formulations prepared, T-ES1 showed the best release rate for the drug, which followed zero order release kinetics with diffusion case II transport mechanism.
Click on an image to view it in the image viewer
There are no comments for this item.